Labetalol in the Preoperative Management of Phaeochromocytoma

Farmer J.B. , Kennedy I. , Levy G.P. , Marshall R.J. Pharmacology of AH5158: a drug which blocks both β- and α-adrenoceptors. Br J Pharmacol 1972; 45: 660–675.

Richards D.A. , Prichard B.N.C. Clinical pharmacology of labetalol. Br J Pharmacol 1979; 8: 89S–93S.

Goodman L.S. , Gilman A. The Pharmacological Basis of Therapeutics. Macmillan, New York 1980; 197.

Richards D.A. , Prichard B.N.C. , Boakes A.J. , Tuckman J. , Knight E.J. Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J 1977; 39: 99–106.

Ross E.J. , Prichard B.N.C. , Kaufman L. , Robertson A.I.G. , Harries B.J. Preoperative and operative management of patients with phaeochromocytoma. Br Med J 1967; 1: 191–198.

Da Prada M. , Zurcher G. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 1976; 19: 1161–1174.

Russell W.J. , Morris R.G. , Frewin D.B. , Drew S.E. Changes in plasma catecholamine concentrations during endotracheal intubation. Br J Anaesth 1981; 53: 837–839.

Bailey R.R. Labetalol in the treatment of a patient with phaeochromocytoma: A case report. Br J Clin Pharmacol 1979; 8: 141S–142S.